3//SEC Filing
Pivotal bioVenture Partners Fund I, L.P. 3
Accession 0001012975-20-000580
CIK 0001722271other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 7:21 PM ET
Size
6.9 KB
Accession
0001012975-20-000580
Insider Transaction Report
Form 3
Akouos, Inc.AKUS
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (1,499,971 underlying)
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (1,499,971 underlying)
Footnotes (2)
- [F1]The Series B Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F2]The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). The general partner of Pivotal is Pivotal bioVenture Partners Fund I G.P., L.P., or Pivotal GP. Robert Hopfner, Vincent Cheung, Peter Bisgaard, and Heather Preston are the managing partners of Pivotal and may be deemed to have shared voting and dispositive power over the shares owned by Pivotal.
Documents
Issuer
Akouos, Inc.
CIK 0001722271
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001695076
Filing Metadata
- Form type
- 3
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 7:21 PM ET
- Size
- 6.9 KB